Global medical affairs manager at UPSA, France
Dr. Rassa Pegahi, a seasoned Global Medical Affairs Manager and Scientific Advisor, has over 18 years of experience in medical affairs and clinical operations. She has led significant projects in various therapeutic areas, including pain, cold and flu, stroke, wound healing, oncology, and Alzheimer’s genetics. With a Ph.D. in Cell and Molecular Biology from the University of Rouen, Dr. Pegahi has extensive expertise in clinical data generation, regulatory submissions, and clinical trial management. Her work includes publishing in international journals, building partnerships with Key Opinion Leaders (KOLs), and supporting product development. Additionally, Dr. Pegahi has trained medical professionals and managed cross-functional teams, showcasing her commitment to advancing healthcare knowledge. Proficient in English, French, and Persian, she is well-equipped for international collaboration. Her broad research experience and leadership make her a distinguished figure in medical research and an asset in the pursuit of innovative health solutions.
Professional Profile
Education
Dr. Rassa Pegahi has a robust academic background centered around molecular biology, clinical research, and project management. She earned her Ph.D. in Cell and Molecular Biology from the University of Rouen, with earlier studies culminating in a Master’s in Cell Biology (Molecular Genetics) and a Master’s in Bio-molecular Chemistry from the same institution and Montpellier University, respectively. She also holds a Certificate of Competent Person in Radioactive Protection from Rouen University, underscoring her technical qualifications in medical research. In 2010, she completed a Clinical Research Project Manager diploma from Paris Descartes University Medical School, furthering her expertise in research management. Dr. Pegahi continued her professional education by obtaining a Clinical Research graduate certification from Clinact-CRO Training Center and a Green Belt certificate from 3M France, reflecting her commitment to quality and process improvement. This multidisciplinary education has empowered her extensive career in global medical affairs and clinical operations.
Professional Experience
Dr. Rassa Pegahi brings over 18 years of experience in medical affairs and clinical operations across diverse therapeutic areas, including pain management, wound healing, and oncology. Since 2020, she has served as Global Medical Affairs Manager at UPSA, where she oversees clinical data strategies, builds scientific partnerships, and supports product development for both prescription and OTC drugs. Previously, as Head of Clinical Operations at Acticor-Biotech, Dr. Pegahi managed clinical trials for stroke immunotherapy, fostering relationships with investigators and handling CRO partnerships. Her role at 3M France involved directing clinical operations for wound healing and vascular access medical devices, as well as authoring scientific publications and organizing conferences. Earlier in her career, she coordinated clinical trials in urology and neurology at Rouen Hospital and contributed to basic research in onco-hematology and molecular genetics. Dr. Pegahi’s extensive, cross-functional experience highlights her leadership and expertise in advancing healthcare solutions globally.
Research Interests
Dr. Rassa Pegahi’s research interests lie at the intersection of clinical innovation and patient-centered healthcare advancements. With a foundation in molecular and cellular biology, her work spans a broad spectrum, including oncology, immunotherapy for stroke, and wound healing technologies. She is particularly interested in developing and validating clinical protocols that improve patient outcomes, evidenced by her focus on investigational drug development, medical devices, and biomarker research in cancer. Dr. Pegahi is also invested in bridging science with practical healthcare applications, collaborating with Key Opinion Leaders (KOLs) to foster medical advancements and ensuring regulatory compliance in clinical studies. Her role in bibliographic research, competitive product analysis, and scientific communication highlights her commitment to staying at the forefront of medical knowledge. Additionally, her experience with pharmacovigilance and market access reflects a keen interest in ensuring patient safety and broadening access to innovative therapeutic solutions in global healthcare.
Awards and Honors
Dr. Rassa Pegahi has received numerous accolades throughout her distinguished career, reflecting her significant contributions to the field of medical affairs and clinical operations. She has been recognized for her leadership in advancing clinical trials and medical research, particularly in areas such as oncology, stroke immunotherapy, and wound healing. Dr. Pegahi’s expertise has been instrumental in the successful development and management of investigational medicinal products and medical devices, earning her trust and recognition from Key Opinion Leaders (KOLs) and scientific communities globally. Her ability to collaborate with cross-functional teams and deliver impactful research has positioned her as a key figure in both scientific and medical spheres. Additionally, Dr. Pegahi’s active participation in international conferences and symposia underscores her commitment to ongoing professional development and knowledge-sharing. While specific formal awards and honors are not listed, her widespread recognition within the healthcare industry and scientific community attests to her exceptional contributions and influence in the field.
Conclusion
Rassa Pegahi has a well-rounded, impactful background in medical affairs, with a strong foundation in clinical research and an extensive publication record. Her comprehensive experience in clinical trials, bibliographic research, and scientific communication make her a strong candidate for the Best Researcher Award. Addressing the suggested areas for improvement could further elevate her profile, potentially positioning her among the top contenders for this honor.
Publications Top Noted
- Title: An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact
- Authors: Mallet, C., Desmeules, J., Pegahi, R., Eschalier, A.
- Journal: Journal of Pain Research
- Year: 2023
- Volume: 16
- Pages: 1081–1094
- Citations: 17
- Title: Exudates absorption and proteases trapping in venous leg ulcers
- Authors: Humbert, P., Courderot-Masuyer, C., Robin, S., Oster, D., Pegahi, R.
- Journal: Journal of Wound Care
- Year: 2017
- Volume: 26
- Issue: 6
- Pages: 346–348
- Citations: 10
- Title: Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia
- Authors: Poyer, F., Coquerel, B., Pegahi, R., Vannier, J.-P., Lamacz, M.
- Journal: Leukemia Research
- Year: 2009
- Volume: 33
- Issue: 3
- Pages: 407–417
- Citations: 27
- Title: Spontaneous and cytokine-evoked production of matrix metalloproteinases by bone marrow and peripheral blood pre-B cells in childhood acute lymphoblastic leukaemia
- Authors: Pegahi, R., Poyer, F., Legrand, E., Vannier, J.-P., Lamacz, M.
- Journal: European Cytokine Network
- Year: 2005
- Volume: 16
- Issue: 3
- Pages: 223–232
- Citations: 13
